Search Results - "JAKUBOWSKI, Ann"

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant by Taur, Ying, Coyte, Katharine, Schluter, Jonas, Robilotti, Elizabeth, Figueroa, Cesar, Gjonbalaj, Mergim, Littmann, Eric R, Ling, Lilan, Miller, Liza, Gyaltshen, Yangtsho, Fontana, Emily, Morjaria, Sejal, Gyurkocza, Boglarka, Perales, Miguel-Angel, Castro-Malaspina, Hugo, Tamari, Roni, Ponce, Doris, Koehne, Guenther, Barker, Juliet, Jakubowski, Ann, Papadopoulos, Esperanza, Dahi, Parastoo, Sauter, Craig, Shaffer, Brian, Young, James W, Peled, Jonathan, Meagher, Richard C, Jenq, Robert R, van den Brink, Marcel R M, Giralt, Sergio A, Pamer, Eric G, Xavier, Joao B

“…Antibiotic treatment can deplete the commensal bacteria of a patient's gut microbiota and, paradoxically, increase their risk of subsequent infections. In…”
Get more information

Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study by Su, Yiqi, Stern, Anat, Karantoni, Eleni, Nawar, Tamara, Han, Gyuri, Zavras, Phaedon, Dumke, Henry, Cho, Christina, Tamari, Roni, Shaffer, Brian, Giralt, Sergio, Jakubowski, Ann, Perales, Miguel Angel, Papanicolaou, Genovefa

“…Cytomegalovirus (CMV)-seropositive (R+) hematopoietic cell transplant (HCT) recipients have a survival disparity compared with CMV-seronegative recipient/donor…”
Get full text

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience by Lin, Andrew, Maloy, Molly, Su, Yiqi, Bhatt, Valkal, DeRespiris, Lauren, Griffin, Meagan, Lau, Carmen, Proli, Anthony, Barker, Juliet, Shaffer, Brian, Giralt, Sergio A., Jakubowski, Ann A., Papadopoulos, Esperanza B., Papanicolaou, Genovefa A., Seo, Susan K., Perales, Miguel‐Angel

“…Cytomegalovirus (CMV) is associated with significant morbidity and mortality in allogeneic hematopoietic cell transplantation (HCT) patients. We evaluated the…”
Get full text

Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies by Stuver, Robert, Shah, Gunjan L., Korde, Neha S., Roeker, Lindsey E., Mato, Anthony R., Batlevi, Connie L., Chung, David J., Doddi, Sital, Falchi, Lorenzo, Gyurkocza, Boglarka, Hamilton, Audrey, Lin, Ya-Hui, Jakubowski, Ann A., Joffe, Erel, Landau, Heather L., Lin, Richard J., Mailankody, Sham, Palomba, M. Lia, Park, Jae H., Perales, Miguel-Angel, Ponce, Doris M., Ramanathan, Lakshmi V., Salles, Gilles A., Scordo, Michael, Seo, Susan K., Shah, Urvi A., Stein, Eytan M., Straus, David, Usmani, Saad Z., Young, James W., Zelenetz, Andrew D., Noy, Ariela, Vardhana, Santosha A.

Get full text

American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer by RIZZO, J. Douglas, BROUWERS, Melissa, JAKUBOWSKI, Ann A, REGAN, David H, SOMERFIELD, Mark R, HURLEY, Patricia, SEIDENFELD, Jerome, ARCASOY, Murat O, SPIVAK, Jerry L, BENNETT, Charles L, BOHLIUS, Julia, EVANCHUK, Darren, GOODE, Matthew J

“…To update American Society of Clinical Oncology/American Society of Hematology recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients…”
Get full text

Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis by Lin, Andrew, Flynn, Jessica, DeRespiris, Lauren, Figgins, Bradley, Griffin, Meagan, Lau, Carmen, Proli, Anthony, Devlin, Sean M., Cho, Christina, Tamari, Roni, Jakubowski, Ann A., Papadopoulos, Esperanza B., Giralt, Sergio A., Perales, Miguel-Angel, Seo, Susan K., Shaffer, Brian

“…•Letermovir is effective in reducing clinically significant cytomegalovirus (CMV) infection in haploidentical or mismatched adult unrelated donor allogeneic…”
Get full text

Human Herpesvirus 6 DNAemia Is Associated With Worse Survival After Ex Vivo T-Cell–Depleted Hematopoietic Cell Transplant by Lee, Yeon Joo, Su, Yiqi, Cho, Christina, Tamari, Roni, Perales, Miguel-Angel, Jakubowski, Ann A, Papanicolaou, Genovefa A

“…Abstract Background We examined the correlation between persistent human herpesvirus 6 (HHV-6) DNAemia (p-HHV-6) and absolute lymphocyte count (ALC), platelet…”
Get full text

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant by Prockop, Susan E, Hasan, Aisha, Doubrovina, Ekaterina, Dahi, Parastoo B, Rodriguez-Sanchez, Irene, Curry, Michael, Mauguen, Audrey, Papanicolaou, Genovefa A, Su, Yiqi, Yao, JinJuan, Arcila, Maria, Boulad, Farid, Castro-Malaspina, Hugo, Cho, Christina, Curran, Kevin J, Giralt, Sergio, Kernan, Nancy A, Koehne, Guenther, Jakubowski, Ann, Papadopoulos, Esperanza, Perales, Miguel-Angel, Politikos, Ioannis, Price, Keith, Selvakumar, Annamalai, Sauter, Craig S, Tamari, Roni, Vizconde, Teresa, Young, James W, O'Reilly, Richard J

“…BackgroundRefractory CMV viremia and disease are associated with significant morbidity and mortality in recipients of hematopoietic stem cell transplant…”
Get full text

American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer by Rizzo, J. Douglas, Brouwers, Melissa, Hurley, Patricia, Seidenfeld, Jerome, Arcasoy, Murat O., Spivak, Jerry L., Bennett, Charles L., Bohlius, Julia, Evanchuk, Darren, Goode, Matthew J., Jakubowski, Ann A., Regan, David H., Somerfield, Mark R.

“…Purpose: To update American Society of Hematology/American Society of Clinical Oncology recommendations for use of erythropoiesis-stimulating agents (ESAs) in…”
Get full text

Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations by Lin, Richard J., Ho, Caleb, Hilden, Patrick D., Barker, Juliet N., Giralt, Sergio A., Hamlin, Paul A., Jakubowski, Ann A., Castro‐Malaspina, Hugo R., Robinson, Kevin S., Papadopoulos, Esperanza B., Perales, Miguel‐Angel, Sauter, Craig S.

“…Summary TP53 alterations portend extremely poor prognosis in patients with mantle cell lymphoma treated with standard treatment modalities. We reviewed…”
Get full text

Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update by RIZZO, J. Douglas, SOMERFIELD, Mark R, RARICK, Mark U, REGAN, David H, LICHTIN, Alan E, HAGERTY, Karen L, SEIDENFELD, Jerome, BOHLIUS, Julia, BENNETT, Charles L, CELLA, David F, DJULBEGOVIC, Benjamin, GOODE, Matthew J, JAKUBOWSKI, Ann A

“…To update the American Society of Clinical Oncology/American Society of Hematology (ASCO/ASH) recommendations for the use of epoetin. The guideline was…”
Get full text

Immune Dysfunction from Radiation Exposure by Hollingsworth, Brynn A., Aldrich, Jennifer T., Case, Cullen M., DiCarlo, Andrea L., Hoffman, Corey M., Jakubowski, Ann A., Liu, Qian, Loelius, Shannon G., PrabhuDas, Mercy, Winters, Thomas A., Cassatt, David R.

“…The hematopoietic system is highly sensitive to ionizing radiation. Damage to the immune system may result in opportunistic infections and hemorrhage, which…”
Get full text

Use of Growth Factors and Other Cytokines for Treatment of Injuries During a Radiation Public Health Emergency by DiCarlo, Andrea L., Horta, Zulmarie Perez, Aldrich, Jennifer T., Jakubowski, Ann A., Skinner, William K., Case, Cullen M.

“…Due to the threat of a radiological or nuclear incident that could impact citizens, the U.S. Department of Health and Human Services tasked the National…”
Get full text

Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies by Lin, Richard J., Elko, Theresa A., Devlin, Sean M., Shahrokni, Armin, Jakubowski, Ann A., Dahi, Parastoo B., Perales, Miguel-Angel, Tamari, Roni, Shaffer, Brian C., Sauter, Craig S., Papadopoulos, Esperanza B., Gyurkocza, Boglarka, Korc-Grodzicki, Beatriz, Barker, Juliet N., Maloy, Molly A., Giralt, Sergio A.

“…Older patients are at increased risk for complications and death following allogeneic hematopoietic cell transplantation (allo-HCT). Traditional…”
Get full text

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation by Fernandez-Viña, Marcelo A., Wang, Tao, Lee, Stephanie J., Haagenson, Michael, Aljurf, Mahmoud, Askar, Medhat, Battiwalla, Minoo, Baxter-Lowe, Lee-Ann, Gajewski, James, Jakubowski, Ann A., Marino, Susana, Oudshoorn, Machteld, Marsh, Steven G.E., Petersdorf, Effie W., Schultz, Kirk, Turner, E. Victoria, Waller, Edmund K., Woolfrey, Ann, Umejiego, John, Spellman, Stephen R., Setterholm, Michelle

“…In subjects mismatched in the HLA alleles C*03:03/C*03:04 no allogeneic cytotoxic T-lymphocyte responses are detected in vitro. Hematopoietic stem cell…”
Get full text

Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation by Perales, Miguel-Angel, Goldberg, Jenna D., Yuan, Jianda, Koehne, Guenther, Lechner, Lauren, Papadopoulos, Esperanza B., Young, James W., Jakubowski, Ann A., Zaidi, Bushra, Gallardo, Humilidad, Liu, Cailian, Rasalan, Teresa, Wolchok, Jedd D., Croughs, Therese, Morre, Michel, Devlin, Sean M., van den Brink, Marcel R.M.

“…Delays in immune recovery after allogeneic hematopoietic stem cell transplantation (allo-HSCT) are associated with increased risks of infection and relapse…”
Get full text

Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period by Mayer, Sebastian, Pastores, Stephen M., Riedel, Elyn, Maloy, Molly, Jakubowski, Ann A.

“…Survival of allogeneic hematopoietic stem cell transplant (aHSCT) recipients in the intensive care unit (ICU) has been poor. We retrospectively analyzed the…”
Get full text

The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation by Elias, Shlomo, Brown, Samantha, Devlin, Sean M, Barker, Juliet N, Cho, Christina, Chung, David J, Dahi, Parastoo B, Giralt, Sergio, Gyurkocza, Boglarka, Jakubowski, Ann A, Lahoud, Oscar B, Landau, Heather, Lin, Richard J, Papadopoulos, Esperanza B, Politikos, Ioannis, Ponce, Doris M, Scordo, Michael, Shaffer, Brian C, Shah, Gunjan L, Tamari, Roni, Young, James W, Perales, Miguel-Angel, Shouval, Roni

“…Comorbidity assessment before allogeneic haematopoietic cell transplantation (allo-HCT) is essential for estimating non-relapse mortality (NRM) risk. We…”
Get full text

Adenovirus Viral Kinetics and Mortality in Ex Vivo T Cell-Depleted Hematopoietic Cell Transplant Recipients With Adenovirus Infection From a Single Center by Lee, Yeon Joo, Fang, Jiaqi, Zavras, Phaedon D, Prockop, Susan E, Boulad, Farid, Tamari, Roni, Perales, Miguel Angel, Papadopoulos, Esperanza B, Jakubowski, Ann A, Giralt, Sergio A, Papanicolaou, Genovefa A

“…Abstract Background We report on predictors of adenovirus (ADV) viremia and correlation of ADV viral kinetics with mortality in ex vivo T-cell depleted (TCD)…”
Get full text

Ionizing radiation exposure after allogeneic hematopoietic cell transplantation by Cho, Christina, Maloy, Molly A., Devlin, Sean M., Aras, Omer, Dauer, Lawrence T., Jakubowski, Ann A., Papadopoulos, Esperanza B., Perales, Miguel-Angel, Rappaport, Theodore S., Giralt, Sergio A.

Get full text